$1.11
0.010.91%
At Close: -
$1.10
-0.01-0.90%
After Hours: Oct 4, 9:12 AM EDT
15 minutes delayed
Comments
Loading...
Rallybio (NASDAQ:RLYB) Stock Quotes, Forecast and News Summary
Rallybio Stock (NASDAQ: RLYB) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Rallybio (RLYB) stock?
You can purchase shares of Rallybio (NASDAQ:RLYB) through any online brokerage.
Who are Rallybio (RLYB) competitors?
Other companies in Rallybio’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Fortress Biotech (NASDAQ:FBIO), HOOKIPA Pharma (NASDAQ:HOOK), Estrella Immunopharma (NASDAQ:ESLA) and Gain Therapeutics (NASDAQ:GANX).
What is the forecast, or price target, for Rallybio (RLYB) stock?
Rallybio has a consensus price target of $8.30.
What is the current price for Rallybio (RLYB)?
The stock price for Rallybio (NASDAQ: RLYB) is $1.1 last updated October 4, 2024 at 9:12 AM EDT.
Does Rallybio (RLYB) pay a dividend?
There are no upcoming dividends for Rallybio.
When is Rallybio (NASDAQ:RLYB) reporting earnings?
Rallybio’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Rallybio (RLYB) going to split?
There is no upcoming split for Rallybio.
What sector and industry does Rallybio (RLYB) operate in?
Rallybio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.